Evidence map

TrialDiabetes, obesity & metabolism2018

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance.

Ren Matsuba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29316197